European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS
Contenuto archiviato il 2024-05-23

European action on anticoagulation (eaa): cost-effectiveness of computer-assisted dosage (eaa computer-dosage)

Obiettivo

Oral Anticoagulant Treatment (OAT) is being used on an increasing scale in EU countries but steps are required to improve poor success of doctors in dosage as, even at specialised centres, patients are only maintained within therapeutic targets for about 50% of the time. Bleeding and thrombosis complications are associated with time "out of control" and labile control, both shown by an EC funded pilot study to be reduced by computer-dosage. A wide-ranging study sufficiently large to provide clinical end-points will be undertaken, to assess the extent to which computerised OAT dosage reduces thrombosis and haemorrhagic complications and is cost-effective. Cost-effectiveness from reduction of clinical complications and demands on medical manpower and administrative savings will be evaluated and the potential for increased provision of OAT within existing resources. Previously funded EC control materials will check conformity to WHO laboratory standards and treatment levels.

Campo scientifico

Programma(i)

Argomento(i)

Invito a presentare proposte

Data not available

Meccanismo di finanziamento

CSC - Cost-sharing contracts

Coordinatore

UNIVERSITY OF MANCHESTER
Contributo UE
Nessun dato
Indirizzo
Oxford Road
MANCHESTER
Regno Unito

Mostra sulla mappa
Collegamenti
Costo totale
Nessun dato

Partecipanti (41)

Condividi questa pagina

Scarica

Ultimo aggiornamento: 12 Aprile 2005

Il mio booklet

Permalink: https://cordis.europa.eu/project/id/QLG4-CT-2001-02175/it

European Union, 2024